Tertiary lymphoid structures as mediators of immunotherapy response

HIGHLIGHTS

  • who: Raj G. Vaghjiani and Joseph J. Skitzki from the Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA have published the article: Tertiary Lymphoid Structures as Mediators of Immunotherapy Response, in the Journal: Cancers 2022, 14, 3748. of /2022/
  • what: As the role of the tumor microenvironment in regulating patient prognosis and therapeu-
  • how: Most intriguing this study was conducted in a patient population in the pretargeted therapy area and almost no patients received trastuzumab .

SUMMARY

    SLO and TLS are broadly characterized as sites wherein . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?